Product Description MagVigen™ – anti-CD20 magnetic nanoparticles are ideal for rapid isolation or depletion of human CD20+progenitor stem cells. MagVigen™ magnetic nanoparticles coated with anti-CD20 monoclonal antibody recognize and efficiently bind to CD20+ cells following a short incubation. The nanoparticle bound CD20+ cells can be separated from the rest of the sample by magnet. MagVigen™- anti-CD20 offers high recovery of high-purity and viable cells for use in further downstream molecular assays. The beads bound cells can be lysed for further protein or nucleic acid analysis. MagVigen™ nanoparticles are much smaller than conventional micro-beads. This feature allows for better accessibility of the nanoparticles to the antigenic epitope on cell surfaces. In addition, the surfaces of MagVigen™ nanoparticles are uniquely coated to reduce non-specific interactions with non-targeted CD20 negative cells.